{"pmcid": 5079604, "prompt_strategy": "zeroshot", "model": "gpt-5.1", "extractions": [{"outcome": "The restricted mean time to hyperglycemia relapse", "intervention": "metformin 1,000 mg daily, sitagliptin 100 mg daily", "comparator": "placebo", "intervention_group_size": 33, "comparator_group_size": 15, "intervention_mean": 480, "comparator_mean": 305, "pmcid": "N/A", "outcome_type": "continuous"}, {"outcome": "The probability of relapse", "intervention": "metformin 1,000 mg daily, sitagliptin 100 mg daily", "comparator": "placebo", "intervention_group_size": 33, "comparator_group_size": 15, "intervention_events": 9, "comparator_events": 11, "pmcid": "N/A", "outcome_type": "binary"}, {"outcome": "Disposition index (DI)", "intervention": "subjects who remained in remission", "comparator": "patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si)", "intervention_group_size": 28, "comparator_group_size": 20, "intervention_mean": 2.0, "comparator_mean": 0.8, "pmcid": "N/A", "outcome_type": "continuous"}, {"outcome": "incremental area under the curve for insulin (AUCi)", "intervention": "subjects who remained in remission", "comparator": "patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si)", "intervention_group_size": 28, "comparator_group_size": 20, "intervention_mean": 8000, "comparator_mean": 3000, "pmcid": "N/A", "outcome_type": "continuous"}, {"outcome": "hyperglycemia relapse-free survival", "intervention": "metformin 1,000 mg daily", "comparator": "sitagliptin 100 mg daily", "intervention_group_size": 17, "comparator_group_size": 16, "pmcid": "N/A", "outcome_type": "continuous"}, {"outcome": "Cox proportional hazards of failure-free survival", "intervention": "metformin 1,000 mg daily", "comparator": "sitagliptin 100 mg daily", "intervention_group_size": 17, "comparator_group_size": 16, "pmcid": "N/A", "outcome_type": "continuous"}, {"outcome": "Hyperglycemia relapse-free survival", "intervention": "metformin 1,000 mg daily, sitagliptin 100 mg daily", "comparator": "placebo", "intervention_group_size": 33, "comparator_group_size": 15, "pmcid": "N/A", "outcome_type": "continuous"}, {"outcome": "The 2-year failure rate", "intervention": "metformin 1,000 mg daily, sitagliptin 100 mg daily", "comparator": "placebo", "intervention_group_size": 33, "comparator_group_size": 15, "intervention_events": 13, "comparator_events": 12, "pmcid": "N/A", "outcome_type": "binary"}], "errors": []}
